{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:30:46Z","timestamp":1793413846649,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jid.2026.05.028","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:51:58Z","timestamp":1781308318000},"page":"3127-3141.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selective blockade of \u03b3c pathway ameliorates alopecia areata in a humanized murine model"],"prefix":"10.1016","volume":"146","author":[{"given":"Wai Chung","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthu Iswarya","family":"Gandhi Sethuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak Keung","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Lam","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Yin Dennis","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lik Hang","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2800-0147","authenticated-orcid":false,"given":"Shaik Abdullah","family":"Nawabjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-0307","authenticated-orcid":false,"given":"Billy Kwok Chong","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anlong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui On","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-2624","authenticated-orcid":false,"given":"Chin Wai","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.05.028_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.jid.5700009","article-title":"Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata","volume":"126","author":"Barahmani","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112721","article-title":"Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFN\u03b3+LPS), M(IL-4) and M(IL-10) phenotypes","volume":"478","author":"Baxter","year":"2020","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jid.2026.05.028_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ard-2023-223850","article-title":"Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story","volume":"83","author":"Bonelli","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2026.05.028_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115798","article-title":"Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease","volume":"44","author":"Dai","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2026.05.028_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1866","article-title":"Blockade of IL-7 signaling suppresses inflammatory responses and reverses alopecia areata in C3H\/HeJ mice","volume":"7","author":"Dai","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jid.2026.05.028_bib7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 blockade inhibits T cell migration into the skin and prevents development of alopecia areata","volume":"197","author":"Dai","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00403-024-03225-4","article-title":"Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study","volume":"316","author":"David","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2026.05.028_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121949","article-title":"High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata","volume":"3","author":"de Jong","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2026.05.028_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.19040","article-title":"Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing","volume":"183","author":"Del Duca","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000530432","article-title":"Alopecia areata: a review of the genetic variants and immunodeficiency disorders associated with alopecia areata","volume":"9","author":"Englander","year":"2023","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.jid.2026.05.028_bib12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/acn3.50820","article-title":"Clinical trial of a humanized anti-IL-2\/IL-15 receptor \u03b2 chain in HAM\/TSP","volume":"6","author":"Enose-Akahata","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jid.2026.05.028_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2022.11.005","article-title":"Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial","volume":"88","author":"Ezzedine","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jcph.1522","article-title":"Results from a first-in-human study of BNZ-1, a selective multicytokine inhibitor targeting members of the common gamma (\u03b3c) family of cytokines","volume":"60","author":"Frohna","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jid.2026.05.028_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jid.2026.05.028_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1521-6616(02)00042-6","article-title":"Transfer of alopecia areata in the human scalp graft\/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response","volume":"106","author":"Gilhar","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.15071","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients","volume":"77","author":"Guttman-Yassky","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2026.05.028_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fimmu.2012.00245","article-title":"The role of the PI3K signaling pathway in CD4(+) T cell differentiation and function","volume":"3","author":"Han","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/1346-8138.17628","article-title":"Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment","volume":"52","author":"Hauber","year":"2025","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib20","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3389\/fimmu.2019.02342","article-title":"Targeting the Janus kinase family in autoimmune skin diseases","volume":"10","author":"Howell","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jimmun\/vkae020","article-title":"Discovery of a new anti-\u03b3c antibody in clinical development for the treatment of autoimmune diseases","volume":"214","author":"Hui","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/ajt.14116","article-title":"A novel xenogeneic graft-versus-host disease model for investigating the pathological role of human CD4+ or CD8+ T cells using immunodeficient NOG mice","volume":"17","author":"Ito","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jid.2026.05.028_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2026.05.028_bib24","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor Baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jid.2026.05.028_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaad.2016.07.056","article-title":"Increased blood levels of NKG2D+CD4+ T cells in patients with alopecia areata","volume":"76","author":"Jang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/exd.70212","article-title":"Possible involvement of skin-resident Memory T Cells in refractory chronic alopecia areata","volume":"35","author":"Kageyama","year":"2026","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.det.2024.09.001","article-title":"Innovation in alopecia areata","volume":"43","author":"Kalil","year":"2025","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2026.05.028_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaad.2021.03.050","article-title":"A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results","volume":"85","author":"King","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/jdv.20547","article-title":"Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the Allegro clinical development programme","volume":"39","author":"King","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2026.05.028_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40257-025-00932-0","article-title":"Safety of baricitinib in adults with severe alopecia areata from two Phase III trials over a median of 2.3 years and Up to 4 years of treatment","volume":"26","author":"King","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-023-00764-w","article-title":"Efficacy and safety of baricitinib in patients with severe alopecia areata over 52 weeks of continuous therapy in two Phase III trials (BRAVE-AA1 and BRAVE-AA2)","volume":"24","author":"Kwon","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(18)30565-8","article-title":"End of the road for daclizumab in multiple sclerosis","volume":"391","author":"Lancet","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2026.05.028_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo0205","article-title":"Blocking common \u03b3 chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models","volume":"15","author":"Le Floc\u2019h","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2026.05.028_bib34","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3389\/fimmu.2019.02293","article-title":"WNT\/\u03b2-catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s13555-023-00941-z","article-title":"The invisible impact of a visible disease: psychosocial impact of alopecia areata","volume":"13","author":"Mesinkovska","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2026.05.028_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"10.1016\/j.jid.2026.05.028_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.crimmu.2021.02.001","article-title":"Immunopathogenesis of alopecia areata","volume":"2","author":"Olayinka","year":"2021","journal-title":"Curr Res Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib38","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ebiom.2019.02.001","article-title":"Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model","volume":"41","author":"Ono","year":"2019","journal-title":"EBiomedicine"},{"key":"10.1016\/j.jid.2026.05.028_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.mcb.2021.12.008","article-title":"Mouse models of graft-versus-host disease","volume":"168","author":"Patel","year":"2022","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.jid.2026.05.028_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jid.2026.05.028_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2026.05.028_bib42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","article-title":"Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652191","article-title":"Resident Memory T Cells in autoimmune skin diseases","volume":"12","author":"Ryan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib45","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.1992.01680150136027","article-title":"Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey","volume":"128","author":"Safavi","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","article-title":"A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring","volume":"13","author":"Samuel","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2026.05.028_bib47","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s13555-025-01517-9","article-title":"Evaluating current and emergent JAK inhibitors for alopecia areata: a narrative review","volume":"15","author":"Sanchez","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2026.05.028_bib48","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00403-002-0354-7","article-title":"Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata","volume":"294","author":"Sato-Kawamura","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2026.05.028_bib49","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41590-023-01547-5","article-title":"A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity","volume":"24","author":"Seok","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30997-3","article-title":"Induction of alopecia areata in C3H\/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma","volume":"8","author":"Shin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2026.05.028_bib51","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","article-title":"Tyrosine kinases Btk and tec regulate osteoclast differentiation by linking RANK and ITAM signals","volume":"132","author":"Shinohara","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jid.2026.05.028_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193601","article-title":"The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium","volume":"13","author":"Starr","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2026.05.028_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140508","article-title":"Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1","volume":"132","author":"Sung","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2026.05.028_bib54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2023.0016","article-title":"Overall and racial and ethnic subgroup prevalences of alopecia areata, alopecia totalis, and alopecia universalis","volume":"159","author":"Sy","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(21)00323-4","article-title":"FDA expands JAK inhibitors warning: going beyond the data?","volume":"3","author":"Thorley","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jid.2026.05.028_bib56","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jdv.20526","article-title":"Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: results from the Allegro-LT phase 3, open-label study","volume":"39","author":"Tziotzios","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2026.05.028_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jdermsci.2020.09.001","article-title":"Pro-inflammatory V\u03b41+T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles","volume":"100","author":"Uchida","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2026.05.028_bib58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1440-1746.2006.04259.x","article-title":"Rapid induction and activation of Tec tyrosine kinase in liver regeneration","volume":"21","author":"Wang","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jid.2026.05.028_bib59","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.3390\/cells10123397","article-title":"The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications","volume":"10","author":"Wa\u015bkiel-Burnat","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.05.028_bib60","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2026.05.028_bib61","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1021\/acschembio.9b00188","article-title":"PF-06651600, a dual JAK3\/TEC family kinase inhibitor","volume":"14","author":"Xu","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jid.2026.05.028_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41392-024-02017-6","article-title":"2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus","volume":"9","author":"Yin","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jid.2026.05.028_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41420-022-00927-4","article-title":"Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease","volume":"8","author":"Yin","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jid.2026.05.028_bib64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5114\/ceji.2020.101264","article-title":"Immunology of alopecia areata","volume":"45","author":"\u017beberkiewicz","year":"2020","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08830185.2023.2274574","article-title":"Low-dose IL-2 therapy in autoimmune diseases: an update review","volume":"43","author":"Zhang","year":"2024","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib66","article-title":"Negative regulation of tec kinase alleviates LPS-induced acute kidney injury in mice via theTLR4\/NF-\u03baB signaling pathway","volume":"2020","author":"Zhang","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jid.2026.05.028_bib67","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/1346-8138.17539","article-title":"Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: a subgroup analysis of the Allegro phase 2b\/3 trial","volume":"52","author":"Zhang","year":"2025","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2026.05.028_bib68","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1074\/jbc.M114.614891","article-title":"Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694","volume":"290","author":"Zhong","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2026.05.028_bib69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia areata: an update on etiopathogenesis, diagnosis, and management","volume":"61","author":"Zhou","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2026.05.028_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1779974","article-title":"Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region","volume":"12","author":"Handlogten","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.jid.2026.05.028_bib71","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jimmun\/vkae020","article-title":"Discovery of a new anti-\u03b3c antibody in clinical development for the treatment of autoimmune diseases","volume":"214","author":"Hui","year":"2025","journal-title":"J Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26026023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26026023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:53:44Z","timestamp":1793411624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26026023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022202X26026023"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.05.028","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective blockade of \u03b3c pathway ameliorates alopecia areata in a humanized murine model","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Investigative Dermatology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}